| Particulars |
|
|
|
| Company Name
| Natco Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
35.82 |
B.V. (₹) |
477.50 |
| Sales(₹ Cr.) |
3,594.60 |
NP (₹ Cr.) |
1,281.50 |
| NP Var% |
-28.00 |
Div% |
250.00 |
| CPS(₹) |
82.10 |
EPS (₹) |
71.50 |
| Traded Value(₹ Lakhs) |
429.31 |
52 Week High |
1,226.00 |
| 52 Week Low |
789.00 |
Price BSE |
864.00 |
| Price NSE |
864.00 |
Market Capital (₹ Cr.) |
15,472.41 |
| P/C Ratio |
10.50 |
P/E Ratio |
12.10 |
| Price Vs.BV |
1.81 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
608.80 |
| NP(₹ Cr.) |
209.60 |
NP Var % |
-51.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
4,119.60 |
| OPM |
54.49 |
NP |
1,838.50 |
| NP Var% |
-27.93 |
EPS |
71.55 |
| PE |
12.07 |
|
|